Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 433

recruiting
3 983
countries
28
conditions
2 109

10 385 trials match your criteria

Appendicitis

Not yet recruiting

Study on the Effects of Moxifloxacin and Drug Combination for Patients with Acute Appendicitis

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years

Cerebellar ataxia

Not yet recruiting

Study on the Effects of Ubiquinol and Ascorbic Acid for Patients with Mitochondrial Disorders and Cerebellar Ataxias

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Ascorbic Acid

Sepsis

Not yet recruiting

Study Comparing Different Antibiotic Treatments for ICU Patients with Hospital-Acquired Sepsis: Focus on Cefepime and Drug Combination

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Avibactam

Pyelonephritis acute

Not yet recruiting

Study on Antibiotic Treatments for Kidney Infection in Children: Comparing Cefixime, Ceftriaxone, and Amikacin for Ages 1 Month to 3 Years

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Trimethoprim

Prostate cancer

Not yet recruiting

Study Comparing Rezvilutamide and Bicalutamide with Hormone Therapy for Patients with Advanced Prostate Cancer

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years

Dementia Alzheimer's type

Not yet recruiting

Study on the Effects of Sabirnetug for Patients with Early Alzheimer's Disease

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years

Sickle cell disease

Not yet recruiting

Study of GBT021601 for Adults and Children with Sickle Cell Disease

Investigational
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years

Colitis ulcerative

Not yet recruiting

Study on the Safety and Effectiveness of Lutikizumab and Adalimumab for Adults with Moderate to Severe Ulcerative Colitis

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Adalimumab

Study on Siplizumab, Cyclophosphamide, and Splenectomy for Preventing Liver Transplant Rejection in Patients Receiving a Deceased Donor Liver

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years

Urethral stenosis

Not yet recruiting

Study on the Safety of Autologous Adipose Tissue-Derived Stromal Vascular Fraction Cells for Patients with Recurrent Urethral Stricture

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years

Skin cancer+1

Not yet recruiting

Study of DYP688 for Patients with Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Sotrovimab
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.